Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px

News > All

Total search results: 7957 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 78 79 80  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
EffRx Pharmaceuticals S.A.. (10/11/16). "Press Release: Lorenzo Bosisio Appointed CEO of EffRx Pharmaceuticals". Freienbach. 2016-10-11
Bone Therapeutics S.A.. (10/11/16). "Press Release: Enrico Bastianelli to Stand Down as CEO of Bone Therapeutics. Thomas Lienard to Become Interim CEO". Gosselies. 2016-10-11
Nasdaq. (10/11/16). "Press Release: Nasdaq Stockholm Welcomes InDex Pharmaceuticals to First North". Stockholm. 2016-10-11
Midatech Pharma plc. (10/11/16). "Press Release: Results of Placing to raise £16.0 million and PDMR Shareholding [Not for United States, Canada, Australia, South Africa, Japan, New Zealand, et al.]". 2016-10-11
Transgene S.A.. (10/11/16). "Press Release: Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study". Strasbourg. 2016-10-11
Hookipa Biotech AG. (10/11/16). "Press Release: Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech". Vienna. 2016-10-11
Bone Therapeutics S.A.. (10/11/16). "Press Release: Transparency Notification Received from Theodorus II SA. Article 14 of the Law of 2 May 2007 on Disclosure of Major Holdings". Gosselies. 2016-10-11
Probiodrug AG. (10/11/16). "Press Release: Probiodrug to Present at US and Japanese Life Science Conferences in October 2016". Halle (Saale). 2016-10-11
Kymab Ltd.. (10/11/16). "Press Release: Bispecific Antibody Agreement with EpimAb". 2016-10-11
CureVac AG. (10/11/16). "Press Release: CureVac Appoints Pierre Kemula as Chief Financial Officer". Tübingen. 2016-10-11
Arcis Biotechnology Ltd.. (10/11/16). "Press Release: Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood". Daresbury. 2016-10-11
PerkinElmer, Inc.. (10/10/16). "Press Release: PerkinElmer's New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs". Waltham, MA & Shanghai. 2016-10-10
bioMérieux S.A.. (10/10/16). "Press Release: BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi Join Forces against Sepsis". 2016-10-10
Molecular Partners AG. (10/10/16). "Press Release: Molecular Partners’ Strategic Partner Allergan to Present Abicipar Phase 2 Data of PALM Study in Diabetic Macular Edema (DME) at the 2016 AAO Annual Meeting". Zürich-Schlieren. 2016-10-10
IntegraGen S.A.. (10/10/16). "Press Release: New Data on IntegraGen’s miR-31-3p Biomarker Featured in Presentation at 2016 ESMO Congress". Copenhagen. 2016-10-10
Agilent Technologies Inc.. (10/10/16). "Press Release: Agilent Technologies Showcases Innovative Laboratory Solutions at Analytica China 2016". Santa Clara, CA. 2016-10-10
Medivir AB. (10/10/16). "Press Release: Medivir Focuses Exclusively on Oncology and Reorganizes to Significantly Reduce the Cost Structure". Stockholm. 2016-10-10
Crescendo Biologics Ltd.. (10/10/16). "Press Release: Crescendo Biologics and Takeda Enter Collaboration for Humabody-based Therapeutics Worth up to $790m". Cambridge & Osaka. 2016-10-10
Helsinn Healthcare S.A.. (10/10/16). "Press Release: Helsinn Group Creates New Investment Fund in 40th Anniversary Year". Lugano. 2016-10-10
Onxeo S.A.. (10/10/16). "Press Release: Onxeo to Present at the 15th Annual BIO Investor Forum in San Francisco". Paris & Copenhagen. 2016-10-10
Selexis S.A.. (10/10/16). "Press Release: Selexis SA Announces Participation at Two Upcoming Industry Conferences". Geneva. 2016-10-10
Ablynx N.V.. (10/10/16). "Press Release: Ablynx Initiates a Phase III Follow-up Study of Its First-in-Class Wholly-owned anti-vWF Nanobody, Caplacizumab, for the Treatment of Acquired TPP". Ghent. 2016-10-10
Nordic Nanovector ASA. (10/10/16). "Press Release: Nordic Nanovector and LegoChem Biosciences Enter Collaboration to Develop Novel Antibody-Drug Conjugates (ADCs) Targeting Leukaemias". Oslo. 2016-10-10
Noxxon Pharma N.V.. (10/10/16). "Press Release: Noxxon Pharma Demonstrates Synergies between NOX-A12 and Therapies Working through T Cells or NK Cells". Berlin. 2016-10-10
Molecular Partners AG. (10/9/16). "Press Release: Molecular Partners Presents Data of MP0250 in an All-comer Phase 1-Study in Solid Tumor Patients and Updates on Phase 2 Studies". Zürich-Schlieren. 2016-10-09
Malin Corporation plc. (10/7/16). "Press Release: Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team". Dublin. 2016-10-07
Newron Pharmaceuticals S.p.A.. (10/7/16). "Press Release: Newron Raises CHF26.1 Mio. in a Private Placement of New Shares [Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia]" 2016-10-07
Ionicon Analytik GmbH. (10/7/16). "Press Release: Ionicon Celebrates Historic Milestone. 300 PTR-MS Instruments Sold". Innsbruck. 2016-10-07
Kite Pharma, Inc.. (10/7/16). "Press Release: Kite Pharma Presents 12-Month Follow-Up Data from ZUMA-1 Phase 1 at the European Society for Medical Oncology (ESMO) Annual Congress". Santa Monica, CA. 2016-10-07
Novo Nordisk A/S. (10/7/16). "Press Release: Novo Nordisk Receives Complete Response Letter in the US for Faster-acting Insulin aspart". Bagsvaerd. 2016-10-07
Merck KGaA. (10/6/16). "Press Release: Merck Unveils New State-of-the-Art M Lab Collaboration Center in Korea". Incheon. 2016-10-06
Bruker Corporation. (10/6/16). "Press Release: Bruker Introduces Enhanced Wine-Profiling Module 3.1 for its NMR FoodScreener". Billerica, MA. 2016-10-06
Probiodrug AG. (10/6/16). "Press Release: Probiodrug Announces Pricing of a EUR 14.9 Million Accelerated Bookbuild Offering of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2016-10-06
Genfit S.A.. (10/6/16). "Press Release: Genfit Successfully Raises EUR 33.9 Million in Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-06
Teva Pharmaceutical Industries Ltd.. (10/6/16). "Press Release: Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership". Jerusalem & Incheon. 2016-10-06
Genzyme Corporation. (10/6/16). "Press Release: BARDA Awards $37.6 Million Contract to Sanofi to Supply Leukine (sargramostim) for Potential Public Health Emergency". Cambridge, MA. 2016-10-06
Thermosome GmbH. (10/6/16). "Press Release: Thermosome Appoints Dr. Ulrich Grau, Dr. Jochen Knolle and Dr. Franz-Robert Klingan to Its Advisory Board". Martinsried. 2016-10-06
BlueBee. (10/6/16). "Press Release: BlueBee Achieves ISO/IEC 27001:2013 Accreditation". 2016-10-06
Orchard Therapeutics Ltd.. (10/6/16). "Press Release: Orchard Therapeutics Announces the Opening of US Operations in Foster City, California". London. 2016-10-06
Vaccinex Inc.. (10/6/16). "Press Release: Vaccinex Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, to Evaluate the Combination of VX15/2503, and Avelumab in Non-Small Cell Lung Cancer". Rochester, NY. 2016-10-06
Novaliq GmbH. (10/6/16). "Press Release: Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer". Heidelberg. 2016-10-06
Kite Pharma, Inc.. (10/6/16). "Press Release: Kite Pharma Initiates Phase 1b/2 Combination Study for KTE-C19 and Atezolizumab in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Santa Monica, CA. 2016-10-06
Molecular Partners AG. (10/6/16). "Press Release: Molecular Partners Regains Rights to Multi-DARPin Drug Candidate Targeting IL-13 & IL-17 for Pulmonary Indications from Janssen". Zürich-Schlieren. 2016-10-06
SGS S.A.. (10/6/16). "Press Release: SGS Investment Launches Precision Agriculture Services In Brazil". 2016-10-06
Probiodrug AG. (10/5/16). "Press Release: Probiodrug Launches Capital Increase by Means of an Accelerated Bookbuild Offering [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2016-10-05
Advanced Accelerator Applications S.A.. (10/5/16). "Press Release: Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares". New York, NY. 2016-10-05
Genfit S.A.. (10/5/16). "Press Release: Genfit Launches a Share Capital Increase through Private Placement [Not for United States, Canada, Australia or Japan]". Lille & Cambridge, MA. 2016-10-05
AgroSavfe N.V.. (10/5/16). "Press Release: AgroSavfe Strengthens Its Management Team". Ghent. 2016-10-05
PX’Therapeutics S.A.. (10/5/16). "Press Release: PX’Therapeutics and Relief Therapeutics Holding AG Announce a Strategic Collaboration Agreement for the Recombinant Production of Atexakin Alfa". Grenoble & Geneva. 2016-10-05
Biodesix, Inc.. (10/5/16). "Press Release: VeriStrat Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy". Boulder, CO. 2016-10-05
Syncona LLP. (10/5/16). "Press Release: Achilles Therapeutics Launched with Funds of £13.2 Million to Develop Immunotherapies for Cancer". 2016-10-05
Mayoly Spindler. (10/5/16). "Press Release: Mayoly Spindler Acquires the Swedish Laboratory Kibion". Paris. 2016-10-05
Genedata AG. (10/4/16). "Press Release: Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support". Basel. 2016-10-04
Evotec AG. (10/4/16). "Press Release: Evotec and Carrick Therapeutics Build Strategic Alliance". Hamburg. 2016-10-04
PharmaMar S.A.. (10/4/16). "Press Release: PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin (plitidepsin) in Korea". Madrid. 2016-10-04
Owlstone Medical Ltd.. (10/4/16). "Press Release: Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer". Cambridge. 2016-10-04
Cellectis S.A.. (10/4/16). "Press Release: Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued in December 2014". New York, NY. 2016-10-04
Grünenthal GmbH. (10/4/16). "Press Release: Gabriel Baertschi Takes Office as New CEO of Grünenthal Group as of October 1, 2016". Aachen. 2016-10-04
Curetis N.V.. (10/4/16). "Press Release: Curetis to Present at Several Investor and Scientific Conferences in the Fourth Quarter 2016". Amsterdam & Holzgerlingen. 2016-10-04
Healx Ltd.. (10/4/16). "Press Release: Healx Announces £1.5m Investment Led by Jonathan Milner". 2016-10-04
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. 2016-10-03
Tecan Group Ltd.. (10/3/16). "Press Release: Tecan Successfully Completes the Acquisition of SPEware Corporation". Männedorf. 2016-10-03
Brainshake Ltd.. (10/3/16). "Press Release: Blood Analysis Company Brainshake Closes Funding of €2M Three Months after First Round". Helsinki & Santa Clara, CA. 2016-10-03
Genfit S.A.. (10/3/16). "Press Release: New Scientific Data to be Presented During Next AASLD Annual Meeting, Strong Involvement in the First-Ever NASH-TAG Conference". Lille & Cambridge, MA. 2016-10-03
ReViral Ltd.. (10/3/16). "Press Release: ReViral Announces Appointment of New Chief Executive Officer". London. 2016-10-03
SGS S.A.. (10/3/16). "Press Release: SGS Announces Investment in New cGMP Facility in Berlin, Germany". 2016-10-03
Prothena Corporation plc. (10/3/16). "Press Release: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director". Dublin. 2016-10-03
Janssen Research & Development, LLC. (10/1/16). "Press Release: New Phase 3 Data Show Significant Efficacy versus Placebo and Superiority of Guselkumab versus Humira in Treatment of Moderate to Severa Plaque Psoriasis". Vienna. 2016-10-01
MorphoSys AG. (10/1/16). "Press Release: MorphoSys Announces that Its Licensee Janssen Reports Positive Results from a Phase 3 Study of Guselkumab in Plaque Psoriasis". 2016-10-01
AstraZeneca plc. (9/30/16). "Press Release: AstraZeneca Presents New Data on Faslodex in Breast Cancer and Provides Immuno-oncology Update at ESMO 2016 Congress". 2016-09-30
Onxeo S.A.. (9/30/16). "Press Release: Onxeo Raises €12.5 Million through Capital Increase with US and European Investors [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-30
Eurofins Scientific. (9/30/16). "Press Release: Eurofins Expands Its Clinical Diagnostic Footprint with the Acquisition of Megalab in Spain". 2016-09-30
Boehringer Ingelheim. (9/30/16). "Press Release: Boehringer Ingelheim Returns Development and Commercial Rights of Olmutinib to Hanmi Pharmaceutical". Ingelheim. 2016-09-30
Biotie Therapies Corporation. (9/30/16). "Press Release: Acorda Therapeutics, Inc. Gains Title to All Shares in Biotie Therapies Corp and the Shares Will Delist from Nasdaq Helsinki". Turku. 2016-09-30
Sanofi S.A.. (9/30/16). "Press Release: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare". Paris. 2016-09-30
Neovacs S.A.. (9/30/16). "Press Release: Half-year Results 2016 and Update on Operational Development". Paris. 2016-09-30
DNA Electronics Ltd.. (9/30/16). "Press Release: BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza". London & Carlsbad, CA. 2016-09-30
Grünenthal GmbH. (9/30/16). "Press Release: Grünenthal’s Cebranopadol, a Novel Strong Analgesic, Meets Pimary Efficacy Endpoint in Phase 3 Trial in Cancer Pain". Yokohama. 2016-09-30
Qiagen N.V.. (9/29/16). "Press Release: Qiagen and ICMP to Develop First NGS Workflow for Identification of Missing Persons". Hilden & The Hague. 2016-09-29
GlaxoSmithKline plc. (9/29/16). "Press Release: GlaxoSmithKline plc Appoints Brian McNamara as CEO of GSK Consumer Healthcare". London. 2016-09-29
Onxeo S.A.. (9/29/16). "Press Release: Onxeo Launches Capital Increase [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen. 2016-09-29
Evotec AG. (9/29/16). "Press Release: Evotec Receives further Important Pre-clinical Milestone in Endometriosis Alliance with Bayer". Hamburg. 2016-09-29
Boehringer Ingelheim. (9/29/16). "Press Release: Boehringer Ingelheim and Sarah Cannon Research Institute Launch Strategic Collaboration to Develop Novel Immune-oncology Therapies". Ingelheim. 2016-09-29
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
DelSiTech Ltd.. (9/29/16). "Press Release: DelSiTech Ltd and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology". Turku. 2016-09-29
Novo Nordisk A/S. (9/29/16). "Press Release: Novo Nordisk Announces Plans to Reduce Workforce by approximately 1,000 Employees". Bagsvaerd. 2016-09-29
Medigene AG. (9/29/16). "Press Release: Bluebird Bio and Medigene Establish Strategic T Cell Receptor (TCR) Alliance in Cancer Immunotherapy". Martinsried & Cambridge, MA. 2016-09-29
Atlantic Healthcare plc. (9/29/16). "Press Release: Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer". Cambridge & Raleigh, NC. 2016-09-29
MorphoSys AG. (9/29/16). "Press Release: MorphoSys and Galapagos Start First-in-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis". 2016-09-29
Rosetta Genomics Ltd.. (9/29/16). "Press Release: Rosetta Genomics Enters Distribution Agreement for RosettaGX Reveal in Israel with Rhenium". Philadeliphia, PA & Rehovot. 2016-09-29
Immunic AG. (9/28/16). "Press Release: Immunic Acquires 4SC’s Immunology Portfolio". Planegg-Martinsried. 2016-09-28
AstraZeneca plc. (9/28/16). "Press Release: AstraZeneca Appoints David Goldstein as Chief Adviser for Its Genomics Initiative". 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Announces Intention to Sell Remaining Holding in Aspen". London. 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Completes Sale of Remaining Aspen Shares". London. 2016-09-28
Evotec AG. (9/28/16). "Press Release: Evotec Enters into Strategic Multi-target Alliance with C4X Discovery". Hamburg. 2016-09-28
Boehringer Ingelheim. (9/28/16). "Press Release: Boehringer Ingelheim Boosts Immune-oncology Pipeline through Collaboration with ViraTherapeutics". Ingelheim. 2016-09-28
Oncodesign S.A.. (9/28/16). "Press Release: GSK and Oncodesign Announce Agreement for Oncodesign’s Acquisition of GSK’s Research Centre in France". 2016-09-28
Microsaic Systems plc. (9/28/16). "Press Release: Retirement of Chairman". 2016-09-28
Merck KGaA. (9/28/16). "Press Release: Merck to Present New Research Focused on Hard-to-Treat Cancers at ESMO 2016 [Not for U.S. and UK media]". Darmstadt. 2016-09-28
Noxxon Pharma N.V.. (9/28/16). "Press Release: Noxxon Pharma NV Lists Its Shares on Alternext Paris [Not for United States, Australia, Canada or Japan or any other jurisdiction where unlawful]". Berlin. 2016-09-28
next pagenext page 1 2 3 ... 78 79 80  next pagenext page



Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top